Concepedia

Fenghua Yu

FY

Statistics

Publications

4

Citations

113

H-Index

4

Active since

2018

Affiliations

Linyi People's Hospital(Current)

Fenghua Yu is an author at Linyi People's Hospital specializing in oncology, molecular oncology, and molecular pathogenesis of retinoblastoma.

Publications per year

2018–2019

4

Publications

4

RETRACTED: Knockdown of lncRNA-H19 inhibits cell viability, migration and invasion while promotes apoptosis via microRNA-143/RUNX2 axis in retinoblastoma

Defeng Qi, Mingming Wang, Fenghua Yu · Biomedicine & Pharmacotherapy · 2018 · 40 citations · Full text

, , +7

RETRACTED: Ginsenoside Rh2 inhibits proliferation but promotes apoptosis and autophagy by down-regulating microRNA-638 in human retinoblastoma cells

Man Li, Duzhen Zhang, Jintao Cheng et al. · Experimental and Molecular Pathology · 2019 · 33 citations

, , +16

Upregulation of BCL2 19 kD Protein-Interacting Protein 3 (BNIP3) is Predictive of Unfavorable Prognosis in Uveal Melanoma

Zhongming Jiang, Fenghua Yu, Man Li · Medical Science Monitor · 2018 · 26 citations · Full text

, , +16

Association of rs11801299 and rs1380576 polymorphisms at MDM4 with risk, clinicopathological features and prognosis in patients with retinoblastoma

Fenghua Yu, Zhongming Jiang, Ai-Ping Song · Cancer Epidemiology · 2019 · 14 citations

, , +9

1–4 of 4